Moderna appoints Michael McDonnell to board
Analysis based on 6 articles · First reported Jul 08, 2026 · Last updated Jul 08, 2026
The appointment is a routine board change and is unlikely to have a significant market impact. It signals Moderna's focus on financial expertise as it advances its pipeline.
On July 8, 2026, Moderna, Inc. announced the appointment of Michael Francis Crotty to its Board of Directors, effective immediately. McDonnell, former CFO of Biogen Inc., brings over 35 years of financial leadership. He will also serve on the Audit Committee. The appointment is part of Moderna's strategy to strengthen its board as it prepares for multiple product launches.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard